Scientific Reports (Apr 2024)

Translational research of boron neutron capture therapy for spinal cord gliomas using rat model

  • Ryo Kayama,
  • Kohei Tsujino,
  • Shinji Kawabata,
  • Yoshiki Fujikawa,
  • Hideki Kashiwagi,
  • Yusuke Fukuo,
  • Ryo Hiramatsu,
  • Takashi Takata,
  • Hiroki Tanaka,
  • Minoru Suzuki,
  • Naonori Hu,
  • Shin-Ichi Miyatake,
  • Toshihiro Takami,
  • Masahiko Wanibuchi

DOI
https://doi.org/10.1038/s41598-024-58728-x
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Boron neutron capture therapy (BNCT) is a type of targeted particle radiation therapy with potential applications at the cellular level. Spinal cord gliomas (SCGs) present a substantial challenge owing to their poor prognosis and the lack of effective postoperative treatments. This study evaluated the efficacy of BNCT in a rat SCGs model employing the Basso, Beattie, and Bresnahan (BBB) scale to assess postoperative locomotor activity. We confirmed the presence of adequate in vitro boron concentrations in F98 rat glioma and 9L rat gliosarcoma cells exposed to boronophenylalanine (BPA) and in vivo tumor boron concentration 2.5 h after intravenous BPA administration. In vivo neutron irradiation significantly enhanced survival in the BNCT group when compared with that in the untreated group, with a minimal BBB scale reduction in all sham-operated groups. These findings highlight the potential of BNCT as a promising treatment option for SCGs.

Keywords